Top 10 Companies in the Southeast Asia 2‑Bromobutyric Acid Market (2026): Market Leaders Powering Regional Chemical Supply

MARKET INSIGHTS

The Southeast Asia 2‑Bromobutyric Acid market was valued at USD 18.5 million in 2024 and is projected to reach USD 25.7 million by 2030, registering a CAGR of 5.6% over the forecast period 2024‑2030. 1,200 metric tons of regional consumption were recorded in 2023, underscoring a steady uptick in demand.

2‑Bromobutyric Acid is an organobromine intermediate that plays a pivotal role in the synthesis of active pharmaceutical ingredients and agrochemical agents. Its dual carboxylic acid and bromine functionalities make it especially suitable for nucleophilic substitution reactions that underpin API manufacturing. The compound is offered in two commercial purity grades—98 % and 99 %—with the higher purity variant increasingly sought by pharmaceutical manufacturers that demand strict impurity control.

Demand drivers are multifaceted: the pharmaceutical sector, which consumed 60 % of the total market in 2023, remains the primary consumer, while the agrochemical industry accounts for 30 %. A 12 % year‑over‑year rise in high‑purity grade demand in 2023 signals a shift toward more stringent quality requirements. Concurrently, manufacturers are allocating 10 % more of their R&D budgets to greener bromination processes, reflecting a broader industry push toward sustainability.

Southeast Asia 2‑Bromobutyric Acid Market – View in Detailed Research Report

Top 10 Companies in the Southeast Asia 2‑Bromobutyric Acid Market

1. Sisco Research Laboratories Pvt. Ltd. (India)
   Headquarters: Pune, India
   Key Offering: 2‑Bromobutyric Acid (98 % & 99 % purity)

   Sisco Research has carved a niche by providing cost‑effective intermediates for both pharmaceutical and agrochemical manufacturers across Southeast Asia. Its manufacturing footprint in India, coupled with a robust supply chain network, enables rapid delivery to regional clients.

   Sustainability & Growth Initiatives:

   • Investing in catalytic bromination processes that lower energy consumption.
   • Partnerships with local universities to develop green chemistry curricula.
   • Adoption of ISO 14001 environmental management standards across all production sites.
2. Merck KGaA (Singapore Branch)
   Headquarters: Singapore
   Key Offering: High‑purity 2‑Bromobutyric Acid (99 %) for pharmaceutical intermediates

   Merck’s Singapore hub serves as a regional distribution center for high‑value chemical intermediates. Its deep R&D capabilities allow the company to tailor product specifications to meet the exacting needs of multinational pharmaceutical OEMs.

   Sustainability & Growth Initiatives:

   • Implementation of closed‑loop water systems in the bromination unit.
   • Targeted investment in biobased bromination feedstocks.
   • Participation in the Singapore Green Initiative to reduce carbon intensity by 20 % by 2030.
3. Loba Chemie Pvt. Ltd. (India)
   Headquarters: New Delhi, India
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for agrochemicals and fine chemicals

   Loba Chemie’s strong foothold in the agrochemical segment stems from its ability to supply large volumes at competitive pricing while maintaining consistent quality.

   Sustainability & Growth Initiatives:

   • Adoption of solar‑powered manufacturing lines.
   • Development of a waste‑to‑energy program for bromination by‑products.
   • Collaboration with regional agrochemical firms to co‑develop sustainable pesticide formulations.
4. Avra Synthesis Pvt. Ltd. (India)
   Headquarters: Bengaluru, India
   Key Offering: 2‑Bromobutyric Acid (98 % & 99 % purity) for specialty fine chemicals

   Avra Synthesis is known for its agility in customizing product specifications for niche applications, particularly in the emerging advanced materials sector.

   Sustainability & Growth Initiatives:

   • Investment in green solvent technologies for bromination.
   • Partnership with Singaporean universities on catalyst development.
   • Implementation of a lean manufacturing framework to reduce waste.
5. Tokyo Chemical Industry Co., Ltd. (Japan)
   Headquarters: Tokyo, Japan
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for agrochemical intermediates

   With a strong presence in Southeast Asia through regional distributors, TCI provides a reliable supply of mid‑grade intermediates that serve a wide range of agrochemical manufacturers.

   Sustainability & Growth Initiatives:

   • Deployment of energy‑efficient reactors in Southeast Asian facilities.
   • Development of a bio‑based bromination route in collaboration with local partners.
   • Commitment to achieving zero‑waste status in all production sites by 2035.
6. Otto Chemie Pvt Ltd. (India)
   Headquarters: Hyderabad, India
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for pharmaceutical intermediates

   Otto Chemie’s focus on high‑quality intermediates has positioned it as a preferred supplier for mid‑tier pharmaceutical manufacturers across the region.

   Sustainability & Growth Initiatives:

   • Adoption of renewable electricity for all manufacturing processes.
   • Implementation of a closed‑loop bromine recovery system.
   • Participation in regional sustainability forums to share best practices.
7. Suvchem Laboratory Chemicals (India)
   Headquarters: Mumbai, India
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for fine chemicals and specialty applications

   Suvchem’s product portfolio is tailored for research institutions and small‑to‑medium manufacturers that require precise control over purity levels.

   Sustainability & Growth Initiatives:

   • Use of biodegradable catalysts in bromination.
   • Collaboration with academic research centers to develop greener synthesis routes.
   • Implementation of a waste‑reduction protocol that cuts by‑product disposal by 30 %.
8. Finar Limited (India)
   Headquarters: Chennai, India
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for agrochemical intermediates

   Finar’s extensive distribution network across South Asia allows it to meet the logistical demands of fast‑growing agrochemical manufacturers.

   Sustainability & Growth Initiatives:

   • Adoption of low‑energy bromination reactors.
   • Partnerships with local farmers to source sustainable feedstocks.
   • Implementation of a carbon‑offset program to neutralise emissions.
9. Central Drug House (P) Ltd. (India)
   Headquarters: Kolkata, India
   Key Offering: 2‑Bromobutyric Acid (98 % purity) for pharmaceutical intermediates

   Central Drug House focuses on providing high‑quality intermediates to mid‑tier pharmaceutical manufacturers in the region.

   Sustainability & Growth Initiatives:

   • Implementation of energy‑saving protocols in the production line.
   • Use of recycled water for cooling processes.
   • Collaboration with regional NGOs to promote safe chemical handling practices.
10. Alfa Aesar (Thermo Fisher Scientific)
    Headquarters: Cleveland, USA (Global distribution via Singapore)
    Key Offering: 2‑Bromobutyric Acid (99 % purity) for high‑value pharmaceutical intermediates

    Alfa Aesar’s global reach and advanced technical support make it a preferred partner for multinational pharmaceutical companies operating in Southeast Asia.

    Sustainability & Growth Initiatives:

    • Investment in renewable energy for all manufacturing facilities.
    • Development of a green bromination platform that reduces hazardous waste.
    • Commitment to zero‑waste operations by 2035.

Download FREE Sample Report

Get Full Report

Outlook (2025‑2034)

Projecting from a 2025 base year of USD 19.5 million, the market is expected to grow to USD 31.7 million by 2034, reflecting a sustained CAGR of 5.6%. The expansion is largely driven by continued investment in regional pharmaceutical manufacturing hubs and the adoption of green bromination technologies that reduce production costs and environmental impact.

Future Trends

• High‑Purity Demand: The 99 % purity segment is projected to capture over 40 % of total sales by 2034, as pharmaceutical companies demand stricter impurity controls.
• Green Chemistry Adoption: R&D spending on sustainable bromination is expected to rise 15 % annually, driven by regulatory pressure and market demand for eco‑friendly intermediates.
• Regional Trade Liberalization: The RCEP framework will continue to lower tariff barriers, enabling greater intra‑ASEAN trade of 2‑Bromobutyric Acid and associated intermediates.
• Supply Chain Resilience: Investment in local production facilities and advanced logistics will reduce exposure to global supply disruptions, particularly for high‑value pharmaceutical intermediates.
• Digitalization: Implementation of digital traceability systems will become standard, enhancing product quality assurance and compliance across the supply chain.